Itaas, Lou Han S.
HRN: 21-39-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/18/2022
07/25/2022
IV
380 Mg
Q6
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes